Development and Validation of a Next-Generation Sequencing-Based Multigene Assay to Predict the Prognosis of Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
Lee HB, Lee SB, Kim M, Kwon S, Jo J, Kim J, Lee HJ, Ryu HS, Lee JW, Kim C, Jeong J, Kim H, Noh DY, Park IA, Ahn SH, Kim S, Yoon S, Kim A, Han W.
Lee HB, et al. Among authors: kim h, kim a, kim c, kim s, kim m, kim j.
Clin Cancer Res. 2020 Dec 15;26(24):6513-6522. doi: 10.1158/1078-0432.CCR-20-2107. Epub 2020 Oct 7.
Clin Cancer Res. 2020.
PMID: 33028590